The first stop for professional medicines advice

Medicines planning

507 results

RelevanceNewest firstOldest firstTitle
Applied filters

Choosing between available adalimumab products

22 February 2023Understand the adalimumab products that are available on contract to the NHS. Choose between them appropriately for organisations or individuals.

PGD Learning Events 2023

21 February 2023We are delighted to announce dates for our three 2023 PGD WebEx events.

PGD Session 3: Q&A

21 February 2023This session is a chance for those who attended sessions 1 or 2 to have their PGD related questions answered by the expert panel.

PGD Session 2

21 February 2023PGDs and medicines mechanisms – what’s new? An update session for those managing and using PGDs and other medicine mechanisms in practice

New Medicines News

5 January 2023

Costing Clinical Trials of ATIMPs using the NIHR iCT - Advice for Pharmacy Sites

12 July 2022Guidance to support and promote consistent pharmacy costing for commercial clinical trials involving ATIMPs.

Preparing to use ranibizumab biosimilar

29 June 2022Ranibizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team

Good governance when implementing ranibizumab biosimilar

29 June 2022Governance should consider processes for approval; procurement and supply; prescribing and administration; monitoring; and pharmacovigilance

The licence and supporting evidence for ranibizumab biosimilar

29 June 2022Three licensed ranibizumab biosimilars are available: Byooviz, Ongavia and Ximluci. Learn about the licensed indications and supporting evidence

Understanding biological and biosimilar medicines

29 June 2022Biosimilar medicines are a type of biological medicine that offer the NHS opportunities to deliver better value for certain conditions